Pharmacokinetics and bioequivalence of fixed-dose combination of candesartan cilexetil/amlodipine besylate (16/10 mg) versus coadministration of individual formulations in healthy subjects

This study compared the pharmacokinetics of a fixed-dose combination (FDC) of candesartan (16 mg) and amlodipine (10 mg) versus coadministration of individual formulations to clarify the bioequivalence of the FDC. In this randomized, open-label, single-dose, 2-treatment, 2-way crossover study, healt...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hae Won, Kang, Woo Youl, Jung, Wookjae, Gwon, Mi-Ri, Yang, Dong Heon, Kim, Eun Hee, Cho, Kyunghee, Yoon, Young-Ran, Seong, Sook Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Clinical Pharmacology and Therapeutics 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327189/
https://www.ncbi.nlm.nih.gov/pubmed/32656160
http://dx.doi.org/10.12793/tcp.2020.28.e8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327189/
https://www.ncbi.nlm.nih.gov/pubmed/32656160
http://dx.doi.org/10.12793/tcp.2020.28.e8

Ejemplares similares